Susan L. Kelley M.D.

Susan L. Kelley M.D.

Board Member at Dare Bioscience, Inc.

Are you Susan L. Kelley M.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Susan L. Kelley M.D.'s network.
  • FOLLOW changes in Susan L. Kelley M.D.'s employment.
  • CONNECT with Susan L. Kelley M.D. through your network of contacts.

Susan L. Kelley M.D.'s Executive Work History


Current
Board Member,
Board Member
IDEAYA Biosciences, Inc. DEF 14A on 04/26/2022
IDEAYA Biosciences, Inc.
Board Member,
Board Member
Dare Bioscience, Inc. DEF 14A on 04/29/2022
Dare Bioscience, Inc.
Board Member,
Board Member
Deciphera Pharmaceuticals, Inc. DEF 14A on 04/26/2022
Deciphera Pharmaceuticals, Inc.
Board Member,
Board Member
Equilar on 12/16/2022
A2 Biotherapeutics, Inc.
Past
To view Susan L. Kelley M.D.'s complete executive work history,
Education
M.D., Duke University - Duke University School of Medicine
Age
67
 

Susan L. Kelley M.D.'s Biography


Susan L. Kelley, M.D. most recently served as Chief Medical Officer of the Multiple Myeloma Research Consortium (MMRC) where she led the strategic design and management of clinical trials in North America. Prior to the MMRC, she held positions of increasing responsibility at Bayer Healthcare Pharmaceuticals and Bayer-Schering Pharma, including Vice President, Global Clinical Development and Therapeutic Area Head – Oncology, where she led the team responsible for the development and worldwide regulatory approval of Nexavar® (sorafenib). Prior to joining Bayer, Dr. Kelley worked at Bristol-Myers Squibb in Oncology and Immunology drug development, ultimately serving as Executive Director, Oncology Clinical Research, at the Bristol-Myers Squibb Pharmaceutical Research Institute. She serves or has served as a member of the Board of Directors at multiple publicly traded companies including Deciphera Pharmaceuticals, Daré Bioscience, VBL Therapeutics Ltd, ArQule and Immune Design. Dr. Kelley received her M.D. from Duke University School of Medicine. She was a Fellow in Medical Oncology and Clinical Fellow in Medicine at Dana-Farber Cancer Institute, Harvard Medical School, and a Fellow in Medical Oncology and Pharmacology at Yale University School of Medicine, where she also served as a Clinical Assistant Professor of Medicine.

Source: IDEAYA Biosciences, Inc. on 12/13/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Susan L. Kelley M.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Susan L. Kelley M.D.'s network.
  • FOLLOW changes in Susan L. Kelley M.D.'s employment.
  • CONNECT with Susan L. Kelley M.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Susan L. Kelley M.D.

Susan L. Kelley M.D.'s Connections (105)


Paul A. Friedman M.D.
Chairman of the Board and Chief Executive Officer, Madrigal Pharmaceuticals, Inc.
Edward E. Penhoet Ph.D.
Director, Alta Partners
Patricia L. Allen
Chief Financial Officer, Vividion Therapeutics, Inc.
Cheryl R. Blanchard Ph.D.
President, Chief Executive Officer and Director, Anika Therapeutics, Inc.
Ron Cohen M.D.
President and Chief Executive Officer, Acorda Therapeutics, Inc.
William T. McKee
Board Observer, MedRhythms, Inc.
Dr. Michael D. Taylor, Ph.D.
Board Member, Mitokinin, Inc.
Ron Squarer
Chairman, ADC Therapeutics SA
Michael Anthony White Ph.D.
SVP, Chief Scientific Officer, IDEAYA Biosciences, Inc.
Steven L. Hoerter
President, Chief Executive Officer and Director, Deciphera Pharmaceuticals, Inc.